危重症患者使用氨基糖苷类药物有哪些新进展？ - Suppr

What is new in the use of aminoglycosides in critically ill patients?

作者信息

Matthaiou Dimitrios K, De Waele Jan, Dimopoulos George

机构信息

Department of Critical Care Medicine, University Hospital ATTIKON, Medical School, University of Athens, 1 Rimini Str, 12462, Haidari-Athens, Greece.

出版信息

Intensive Care Med. 2014 Oct;40(10):1553-5. doi: 10.1007/s00134-014-3376-7. Epub 2014 Jul 4.

DOI:10.1007/s00134-014-3376-7

PMID:24993463

Abstract

摘要

相似文献

What is new in the use of aminoglycosides in critically ill patients?

Intensive Care Med. 2014 Oct;40(10):1553-5. doi: 10.1007/s00134-014-3376-7. Epub 2014 Jul 4.

Comment: once-daily aminoglycoside dosing in critically ill patients.

Ann Pharmacother. 1998 Oct;32(10):1109-10. doi: 10.1345/aph.17243b.

The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients.

Surg Infect (Larchmt). 2009 Dec;10(6):563-70. doi: 10.1089/sur.2007.080.

Aminoglycosides for life-threatening infections: a plea for an individualized approach using intensive therapeutic drug monitoring.

Minerva Anestesiol. 2014 Oct;80(10):1135-42. Epub 2013 Dec 11.

Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.

Clin Pharmacokinet. 2020 Feb;59(2):173-205. doi: 10.1007/s40262-019-00813-w.

[Rational use of aminoglycoside antibiotics on the basis of pharnacokinetics and pharmacodynamics theory].

Zhonghua Jie He He Hu Xi Za Zhi. 2012 Oct;35(10):726-8.

Comments to consensus document. Once-daily dosing of aminoglycosides from N. Anaizi. A supplement to dosage and monitoring in critically ill patients.

Int J Clin Pharmacol Ther. 1997 Sep;35(9):397.

Can Intra-abdominal Pressure Predict the Pharmacokinetics of Aminoglycosides in Critically Ill Patients With Intra-abdominal Sepsis?

Am J Ther. 2022;29(3):e376-e378. doi: 10.1097/MJT.0000000000001404. Epub 2021 Jun 11.

A no-nonsense approach to hereditary kidney disease.

Pediatr Nephrol. 2020 Nov;35(11):2031-2042. doi: 10.1007/s00467-019-04394-5. Epub 2019 Dec 5.

Fidaxomicin therapy in critically ill patients with Clostridium difficile infection.

Antimicrob Agents Chemother. 2015 Mar;59(3):1776-81. doi: 10.1128/AAC.04268-14. Epub 2014 Dec 22.

引用本文的文献

Use of Gentamicin for Sepsis and Septic Shock in Anaesthesia-Intensive Care Unit: A Clinical Practice Evaluation.

Turk J Anaesthesiol Reanim. 2020 Oct;48(5):399-405. doi: 10.5152/TJAR.2019.57255. Epub 2019 Dec 26.

Focus on adequate antimicrobial treatment and de-escalation in the ICU.

Intensive Care Med. 2016 Dec;42(12):1856-1858. doi: 10.1007/s00134-016-4566-2. Epub 2016 Sep 29.

Focus on optimization of early antimicrobial therapy in ICU-acquired infections.

Intensive Care Med. 2016 Nov;42(11):1658-1660. doi: 10.1007/s00134-016-4485-2. Epub 2016 Aug 11.

Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics.

Intensive Care Med. 2015 Apr;41(4):575-88. doi: 10.1007/s00134-015-3755-8. Epub 2015 Mar 26.

Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock.

Antimicrob Agents Chemother. 2014 Dec;58(12):7468-74. doi: 10.1128/AAC.03750-14. Epub 2014 Oct 6.

本文引用的文献

Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen.

Intensive Care Med. 2014 Jul;40(7):998-1005. doi: 10.1007/s00134-014-3276-x. Epub 2014 Apr 1.

Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011).

Diagn Microbiol Infect Dis. 2014 Apr;78(4):443-8. doi: 10.1016/j.diagmicrobio.2013.11.025. Epub 2013 Dec 6.

Aminoglycosides for life-threatening infections: a plea for an individualized approach using intensive therapeutic drug monitoring.

Minerva Anestesiol. 2014 Oct;80(10):1135-42. Epub 2013 Dec 11.

Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options.

Clin Microbiol Infect. 2014 Feb;20(2):O117-23. doi: 10.1111/1469-0691.12341. Epub 2013 Aug 30.

Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study.

Crit Care. 2013 Aug 14;17(4):R174. doi: 10.1186/cc12853.

Evaluating amikacin dosage regimens in intensive care unit patients: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.

Int J Antimicrob Agents. 2013 Aug;42(2):155-60. doi: 10.1016/j.ijantimicag.2013.04.021. Epub 2013 Jun 5.

Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis.

Intensive Care Med. 2013 Jul;39(7):1247-52. doi: 10.1007/s00134-013-2909-9. Epub 2013 Apr 20.

Aerosol therapy during mechanical ventilation: an international survey.

Intensive Care Med. 2013 Jun;39(6):1048-56. doi: 10.1007/s00134-013-2872-5. Epub 2013 Mar 23.

Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis.

Lancet Infect Dis. 2013 Apr;13(4):328-41. doi: 10.1016/S1473-3099(12)70322-5. Epub 2013 Jan 25.

An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration.

BMC Pharmacol Toxicol. 2012 Nov 8;13:14. doi: 10.1186/2050-6511-13-14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

What is new in the use of aminoglycosides in critically ill patients?

作者信息

Matthaiou Dimitrios K, De Waele Jan, Dimopoulos George

机构信息

Department of Critical Care Medicine, University Hospital ATTIKON, Medical School, University of Athens, 1 Rimini Str, 12462, Haidari-Athens, Greece.

出版信息

Intensive Care Med. 2014 Oct;40(10):1553-5. doi: 10.1007/s00134-014-3376-7. Epub 2014 Jul 4.

DOI:10.1007/s00134-014-3376-7

PMID:24993463

Abstract

摘要

相似文献

What is new in the use of aminoglycosides in critically ill patients?

Intensive Care Med. 2014 Oct;40(10):1553-5. doi: 10.1007/s00134-014-3376-7. Epub 2014 Jul 4.

Comment: once-daily aminoglycoside dosing in critically ill patients.

Ann Pharmacother. 1998 Oct;32(10):1109-10. doi: 10.1345/aph.17243b.

The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients.

Surg Infect (Larchmt). 2009 Dec;10(6):563-70. doi: 10.1089/sur.2007.080.

Aminoglycosides for life-threatening infections: a plea for an individualized approach using intensive therapeutic drug monitoring.

Minerva Anestesiol. 2014 Oct;80(10):1135-42. Epub 2013 Dec 11.

Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.

Clin Pharmacokinet. 2020 Feb;59(2):173-205. doi: 10.1007/s40262-019-00813-w.

[Rational use of aminoglycoside antibiotics on the basis of pharnacokinetics and pharmacodynamics theory].

Zhonghua Jie He He Hu Xi Za Zhi. 2012 Oct;35(10):726-8.

Comments to consensus document. Once-daily dosing of aminoglycosides from N. Anaizi. A supplement to dosage and monitoring in critically ill patients.

Int J Clin Pharmacol Ther. 1997 Sep;35(9):397.

Can Intra-abdominal Pressure Predict the Pharmacokinetics of Aminoglycosides in Critically Ill Patients With Intra-abdominal Sepsis?

Am J Ther. 2022;29(3):e376-e378. doi: 10.1097/MJT.0000000000001404. Epub 2021 Jun 11.

A no-nonsense approach to hereditary kidney disease.

Pediatr Nephrol. 2020 Nov;35(11):2031-2042. doi: 10.1007/s00467-019-04394-5. Epub 2019 Dec 5.

Fidaxomicin therapy in critically ill patients with Clostridium difficile infection.

Antimicrob Agents Chemother. 2015 Mar;59(3):1776-81. doi: 10.1128/AAC.04268-14. Epub 2014 Dec 22.

引用本文的文献

Use of Gentamicin for Sepsis and Septic Shock in Anaesthesia-Intensive Care Unit: A Clinical Practice Evaluation.

Turk J Anaesthesiol Reanim. 2020 Oct;48(5):399-405. doi: 10.5152/TJAR.2019.57255. Epub 2019 Dec 26.

Focus on adequate antimicrobial treatment and de-escalation in the ICU.

Intensive Care Med. 2016 Dec;42(12):1856-1858. doi: 10.1007/s00134-016-4566-2. Epub 2016 Sep 29.

Focus on optimization of early antimicrobial therapy in ICU-acquired infections.

Intensive Care Med. 2016 Nov;42(11):1658-1660. doi: 10.1007/s00134-016-4485-2. Epub 2016 Aug 11.

Intensive Care Med. 2015 Apr;41(4):575-88. doi: 10.1007/s00134-015-3755-8. Epub 2015 Mar 26.

Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock.

Antimicrob Agents Chemother. 2014 Dec;58(12):7468-74. doi: 10.1128/AAC.03750-14. Epub 2014 Oct 6.

本文引用的文献

Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen.

Intensive Care Med. 2014 Jul;40(7):998-1005. doi: 10.1007/s00134-014-3276-x. Epub 2014 Apr 1.

Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011).

Diagn Microbiol Infect Dis. 2014 Apr;78(4):443-8. doi: 10.1016/j.diagmicrobio.2013.11.025. Epub 2013 Dec 6.

Aminoglycosides for life-threatening infections: a plea for an individualized approach using intensive therapeutic drug monitoring.

Minerva Anestesiol. 2014 Oct;80(10):1135-42. Epub 2013 Dec 11.

Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options.

Clin Microbiol Infect. 2014 Feb;20(2):O117-23. doi: 10.1111/1469-0691.12341. Epub 2013 Aug 30.

Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study.

Crit Care. 2013 Aug 14;17(4):R174. doi: 10.1186/cc12853.

Evaluating amikacin dosage regimens in intensive care unit patients: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.

Int J Antimicrob Agents. 2013 Aug;42(2):155-60. doi: 10.1016/j.ijantimicag.2013.04.021. Epub 2013 Jun 5.

Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis.

Intensive Care Med. 2013 Jul;39(7):1247-52. doi: 10.1007/s00134-013-2909-9. Epub 2013 Apr 20.

Aerosol therapy during mechanical ventilation: an international survey.

Intensive Care Med. 2013 Jun;39(6):1048-56. doi: 10.1007/s00134-013-2872-5. Epub 2013 Mar 23.

Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis.

Lancet Infect Dis. 2013 Apr;13(4):328-41. doi: 10.1016/S1473-3099(12)70322-5. Epub 2013 Jan 25.

An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration.

BMC Pharmacol Toxicol. 2012 Nov 8;13:14. doi: 10.1186/2050-6511-13-14.

What is new in the use of aminoglycosides in critically ill patients?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

What is new in the use of aminoglycosides in critically ill patients?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献